OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Optimizerx Corporation (OPRX) Misses Q1 EPS by 3c, Revenues Beat
May 4, 2020 4:40 PM EDTOptimizerx Corporation (NASDAQ: OPRX) reported Q1 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.89 million.
Q1 2020 Financial Highlights
Total year over year revenue increased 46% to a record $7.6 million.Year over year gross profit increased 20% to $4.3 million.Cash and cash equivalents totaled $15.2 million at March 31, 2020.Q1 2020 Operational Highlights
Secured several multi-million-dollar enterprise-level engagements for access to OptimizeRxs fully integrated communications platform, further transitioning the company to a recurring revenue model. OptimizeRx Innovation Lab launched... More


